172 - Bug to Drug: Translating Mechanisms of Antimicrobial Resistance to Treatment of Challenging Infections

Tuesday, October 21, 2025

3:15 PM - 4:30 PM US ET

Location: Thomas B. Murphy Ballroom 1

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Luther Bartelt, MD

Associate Professor, Infectious Diseases
University of North Carolina School of Medicine
Chapel Hill, NC, United States
TA

Tessa Andermann, MD, MPH (she/her/hers)

Assistant Professor of Medicine
Medicine/Division of Infectious Diseases
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States

Faculty(s)

Ayesha Khan

University of California-Irvine Health
Jose Munita, MD

MD
Instituto de Ciencias e Innovación en Medicina
Santiago, Region Metropolitana, Chile
Samuel Aitken, PharmD, MPH (he/him/his)

Clinical Pharmacist Specialist
Department of Pharmacy
Michigan Medicine
Ann Arbor, MI, United States

Disclosure(s):

Luther A. Bartelt, MD: No financial relationships to disclose.

Tessa Andermann, MD, MPH: Seres Therapeutics: Advisor/Consultant

Ayesha Khan: No financial relationships to disclose.

Jose M. Munita, MD: MSD LATAM: Grant/Research Support; Pfizer, Inc.: Grant/Research Support

Samuel L. Aitken, PharmD, MPH: Merck and Company, Inc.: Advisor/Consultant; Shionogi & Company, Limited: Advisor/Consultant

Learning Objectives:

At the conclusion of this session, participants will be able to:

review examples of how antimicrobial resistance research informs clinical practice in real-time;
describe examples of how clinical outcomes inform antimicrobial resistance in real time;
discuss how antimicrobial research informs clinical care in low-resource settings.

Presentations:

3:15 PM - 3:40 PM US ET

Bench-to-Bedside: How Antimicrobial Resistance Research Can Shape Real-Time Practice
Speaker: Samuel L. Aitken, PharmD, MPH (he/him/his) – Michigan Medicine
3:40 PM - 4:05 PM US ET

Bedside-to-Bench: How Clinical Treatment Failures Drive Discovery of New Mechanisms of Resistance
Speaker: Ayesha Khan – University of California-Irvine Health
4:05 PM - 4:30 PM US ET

Translational Antimicrobial Resistance Research in Low-Resource Settings
Speaker: Jose M. Munita, MD – Instituto de Ciencias e Innovación en Medicina